Does IV vitamin therapy work? The trials were run on hospital patients
The serious trials of IV vitamin therapy tested people already in hospital, not healthy adults, and the largest found no benefit.
Educational, not medical advice. Always consult a qualified healthcare provider before changing your diet, supplements, or routine. Full disclaimer.
Recommendation
No published trial has tested the vitamin drips sold in wellness clinics on healthy people. The serious research into vitamins given into a vein was done on hospital patients, and the largest of those trials, covering 1,568 critically ill and 1,022 less sick patients with COVID-19, found no benefit and was stopped early [5]. An infusion does put far more vitamin C into the blood than the same amount swallowed [4], but a higher blood level is not the same thing as feeling or living better.
The findings
IV vitamin therapy has not been tested on the people who mostly pay for it. Every large randomised trial of intravenous vitamins - vitamins delivered straight into a vein through a drip rather than swallowed - recruited patients who were already ill in hospital, and the biggest of them found no benefit.
Two linked trials across 90 intensive care sites and 40 other hospital sites on four continents gave patients hospitalised with COVID-19 either vitamin C into a vein every six hours for four days, or a placebo [5]. Among the 1,568 critically ill patients, 61.9% of the vitamin C group survived to leave hospital against 64.6% of the comparison group; among the 1,022 who were not critically ill it was 85.1% against 86.6% [5]. Neither difference favoured vitamin C, and recruitment was halted early once the results crossed the study's own thresholds for futility and possible harm [5].
A pooled analysis of 18 randomised trials covering 2,001 critically ill patients found much the same, with one small exception [6]. Vitamin C by infusion shortened intensive care stays by roughly nine hours and hospital stays by about a day and a half, but made no difference to how many patients died or how badly their organs failed [6]. The authors' own verdict was that their pooled data could not settle the question.
The cancer research that drip clinics point to is early-stage. Small first-in-human safety studies have found high-dose vitamin C infusions tolerable, but a 2021 review of that literature concluded that the large trials that decide whether a treatment actually works are missing [2]. The most-quoted mechanism work, on pancreatic cancer, was done in cultured cells and in mice [10].
Infusions do have a settled place in medicine, and it is narrower than a clinic menu suggests. A 2024 gastroenterology practice update reserves intravenous iron - iron is a mineral, not a vitamin - for people who cannot tolerate or absorb the tablets, such as after weight-loss surgery or with active inflammatory bowel disease [13]. A review of 36 studies covering 2,339 patients on nutrients for wound healing reported improvements for particular wound types but found no official recommendation for using vitamins and minerals to speed healing up [3].
Why it works
Swallowing a vitamin and infusing one are genuinely different, and the gut is the reason. When 17 healthy volunteers took 1.25 grams of vitamin C by mouth, the amount dissolved in their blood peaked at about 135 micromol/L - micromoles per litre, a way of measuring how much of a substance is floating in the blood - while the same 1.25 grams into a vein peaked at about 885 [4].
That gap widens as the dose rises. Modelling in the same study predicted that the most vitamin C a person can swallow before their stomach rebels would top out near 220, while a 50-gram infusion would reach roughly 13,400 [4]. The gut absorbs only so much at a time, and the kidneys flush the surplus: predicted urine concentrations after an infusion ran about 140 times higher than after the largest oral doses [4].
So the pharmacological case for a drip is real. It is the only way to reach those concentrations, which is exactly why researchers studying vitamin C as a cancer drug use infusions rather than tablets [2].
What the blood levels do not establish is that reaching them helps. The gap between swallowed and infused is the premise of intravenous vitamin research, not its result - and when trials went looking for the result in patients, it was not there [5].
17 healthy volunteers; average peak concentrations Data from source [4]
Limitations
No trial has tested a wellness drip on a healthy person, so everything above is borrowed evidence. Being specific about who these studies do not describe:
- The participants were in intensive care or hospitalised with COVID-19 [5], or critically ill across 18 further trials [6]. None of them resembles a well adult booking an appointment.
- Almost all of this research tested vitamin C on its own at doses far beyond anything in food, so it says nothing about the mixed vitamin and mineral bags sold for energy or immunity.
- The pancreatic cancer results came from cells in dishes and from mice [10], and what works in a mouse frequently fails in people.
- The iron guidance is an expert review rather than a systematic one, by its own authors' description, and it covers diagnosed iron deficiency anaemia rather than topping up someone whose levels are fine [13].
On safety, the evidence here is similarly narrow. With intravenous iron, true anaphylaxis - a severe whole-body allergic reaction - is very rare, and most reactions are milder responses to the infusion itself [13]. That describes iron given under medical supervision for a diagnosed deficiency, not every bag on a clinic menu. Whether an infusion of anything makes sense for a particular person is a clinical decision taken with a doctor.
Real-world example
Longevity clinics list intravenous vitamin therapy next to services like DEXA scans and biomarker panels, and a first appointment is usually undramatic: a short consultation, sometimes bloodwork, then a nurse places a small tube into a vein in your arm and you sit while the bag empties.
The question worth asking is not whether the drip is safe but what it is meant to do that swallowing the same nutrients would not. The one thing an infusion reliably changes is the peak level in your blood [4]. If the answer you get is about outcomes - more energy, faster recovery - it is worth knowing that the trials which measured outcomes measured them in hospital patients, and came back with nothing [5].
Primary paper
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Adhikari NKJ, et al.
JAMA, 2023
View paper on publisher websiteSources
Numbers in brackets [1], [2]… in the body link to this list.
- [1]
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Diaz LA, Shiu KK, Kim TW, et al. · The Lancet. Oncology · 2022
doi.org/10.1016/S1470-2045(22)00197-8 - [2]
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Böttger F, Vallés-Martí A, Cahn L, et al. · Journal of experimental & clinical cancer research : CR · 2021
doi.org/10.1186/s13046-021-02134-y - [3]
Evidence-Based Nutritional Interventions in Wound Care.
Saeg F, Orazi R, Bowers GM, et al. · Plastic and reconstructive surgery · 2021
doi.org/10.1097/PRS.0000000000008061 - [4]
Vitamin C pharmacokinetics: implications for oral and intravenous use.
Padayatty SJ, Sun H, Wang Y, et al. · Annals of internal medicine · 2004
doi.org/10.7326/0003-4819-140-7-200404060-00010 - [5]
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Adhikari NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, et al. · JAMA · 2023
doi.org/10.1001/jama.2023.21407 - [6]
The efficacy of intravenous vitamin C in critically ill patients: A meta-analysis of randomized controlled trials.
Xing X, Xu M, Yang L, et al. · Clinical nutrition (Edinburgh, Scotland) · 2021
doi.org/10.1016/j.clnu.2021.03.007 - [7]
Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas.
Isaac I, Patel L, Tran N, et al. · Advanced materials (Deerfield Beach, Fla.) · 2025
doi.org/10.1002/adma.202507657 - [8]
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, et al. · Critical care (London, England) · 2016
doi.org/10.1186/s13054-016-1208-6 - [9]
Propofol.
Vanlersberghe C, Camu F · Handbook of experimental pharmacology · 2008
doi.org/10.1007/978-3-540-74806-9_11 - [10]
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism.
O'Leary BR, Alexander MS, Du J, et al. · Scientific reports · 2020
doi.org/10.1038/s41598-020-74806-2 - [11]
Glucocorticoid induced osteoporosis.
Hu K, Adachi JD · Expert review of endocrinology & metabolism · 2019
doi.org/10.1080/17446651.2019.1617131 - [12]
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Sharman JP, Egyed M, Jurczak W, et al. · Lancet (London, England) · 2020
doi.org/10.1016/S0140-6736(20)30262-2 - [13]
AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review.
DeLoughery TG, Jackson CS, Ko CW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
doi.org/10.1016/j.cgh.2024.03.046 - [14]
Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
Lau WL, Obi Y, Kalantar-Zadeh K · Clinical journal of the American Society of Nephrology : CJASN · 2018
doi.org/10.2215/CJN.10390917 - [15]
Approach to treatment of hypophosphatemia.
Felsenfeld AJ, Levine BS · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2012
doi.org/10.1053/j.ajkd.2012.03.024